What is he best known for?
The fields of study he is best known for:
- Statistics
- Internal medicine
- Surgery
Douglas G. Altman mostly deals with MEDLINE, Research design, Clinical trial, Systematic review and Checklist.
The MEDLINE study combines topics in areas such as Guideline, Randomized controlled trial, Statement, Family medicine and Intensive care medicine.
His research in Research design intersects with topics in Medical physics, Medical research and Set.
His Systematic review research is multidisciplinary, relying on both Meta-analysis, Publication bias, Health care and Evidence-based medicine.
His Checklist research includes elements of Observational study, Applied psychology, Medical education, Clinical study design and Critical appraisal.
In his research on the topic of Alternative medicine, Statistics is strongly related with Data mining.
His most cited work include:
- Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (43090 citations)
- Statistical methods for assessing agreement between two methods of clinical measurement. (38236 citations)
- Statistical methods for assessing agreement between two methods of clinical measurement. (38236 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in MEDLINE, Randomized controlled trial, Clinical trial, Research design and Family medicine.
His research in MEDLINE is mostly concerned with Systematic review.
The various areas that Douglas G. Altman examines in his Systematic review study include Meta-analysis, Health care and Evidence-based medicine.
His Randomized controlled trial research incorporates elements of Physical therapy, Sample size determination and Data mining.
He has included themes like Medical physics, Pediatrics and Intensive care medicine in his Clinical trial study.
His Checklist study integrates concerns from other disciplines, such as Clinical study design, Quality and Medical education.
He most often published in these fields:
- MEDLINE (23.69%)
- Randomized controlled trial (17.22%)
- Clinical trial (16.65%)
What were the highlights of his more recent work (between 2014-2021)?
- MEDLINE (23.69%)
- Checklist (11.32%)
- Clinical trial (16.65%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in MEDLINE, Checklist, Clinical trial, Randomized controlled trial and Family medicine.
Particularly relevant to Systematic review is his body of work in MEDLINE.
His research investigates the connection between Systematic review and topics such as Psychological intervention that intersect with issues in Health care.
Douglas G. Altman usually deals with Checklist and limits it to topics linked to Consolidated Standards of Reporting Trials and Transparency.
His study focuses on the intersection of Clinical trial and fields such as Alternative medicine with connections in the field of Intensive care medicine.
His studies in Randomized controlled trial integrate themes in fields like Physical therapy, Data mining and Epidemiology.
Between 2014 and 2021, his most popular works were:
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. (2993 citations)
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (1949 citations)
- Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. (1478 citations)
In his most recent research, the most cited papers focused on:
- Statistics
- Internal medicine
- Surgery
Douglas G. Altman mainly investigates MEDLINE, Checklist, Research design, Systematic review and Clinical trial.
His MEDLINE study combines topics from a wide range of disciplines, such as Observational study, Delphi method, Data mining, Randomized controlled trial and Evidence-based practice.
His studies deal with areas such as Statistics and N of 1 trial as well as Data mining.
His Checklist research is multidisciplinary, relying on both Alternative medicine, Consolidated Standards of Reporting Trials, Health care and Medical education.
In his study, Evidence-based medicine is inextricably linked to Family medicine, which falls within the broad field of Consolidated Standards of Reporting Trials.
His biological study spans a wide range of topics, including Psychological intervention, Meta-analysis and Confounding.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
